TY - JOUR
T1 - A Genetics-First Approach Revealed Monogenic Disorders in Patients With ARM and VACTERL Anomalies
AU - van de Putte, Romy
AU - Dworschak, Gabriel C.
AU - Brosens, Erwin
AU - Reutter, Heiko M.
AU - Marcelis, Carlo L. M.
AU - Acuna-Hidalgo, Rocio
AU - Kurtas, Nehir E.
AU - Steehouwer, Marloes
AU - Dunwoodie, Sally L.
AU - Schmiedeke, Eberhard
AU - Maerzheuser, Stefanie
AU - Schwarzer, Nicole
AU - Brooks, Alice S.
AU - de Klein, Annelies
AU - Sloots, Cornelius E. J.
AU - Tibboel, Dick
AU - Brisighelli, Giulia
AU - Morandi, Anna
AU - Bedeschi, Maria F.
AU - Bates, Michael D.
AU - Levitt, Marc A.
AU - Pena, Alberto
AU - de Blaauw, Ivo
AU - Roeleveld, Nel
AU - Brunner, Han G.
AU - van Rooij, Iris A. L. M.
AU - Hoischen, Alexander
N1 - Funding Information:
We would like to thank Ernesto Leva for his involvement in recruiting patients and their parents from Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan, Italy, and Angela Mendell for processing genetic samples from patients and their parents at Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. In addition, we are grateful to the patients and their parents for their willingness to participate. Funding. RP was supported by a personal research grant from the Radboud university medical center, Nijmegen, the Netherlands. GD was supported by BONFOR grant O-120.0001. EB was supported by a grant (SSWO S13-9) of the Friends of Sophia Foundation. HR was supported by grant 2014_A14 from the Else Kröner-Fresenius Foundation, and by the grants RE 1723/1-1, RE 1723/1-3, and RE 1723/2-1 from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG). AH and HB were supported by the Solve-RD project. The Solve-RD project received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 779257.
Publisher Copyright:
© Copyright © 2020 van de Putte, Dworschak, Brosens, Reutter, Marcelis, Acuna-Hidalgo, Kurtas, Steehouwer, Dunwoodie, Schmiedeke, Märzheuser, Schwarzer, Brooks, de Klein, Sloots, Tibboel, Brisighelli, Morandi, Bedeschi, Bates, Levitt, Peña, de Blaauw, Roeleveld, Brunner, van Rooij and Hoischen.
PY - 2020/6/23
Y1 - 2020/6/23
N2 - Background:The VATER/VACTERL association (VACTERL) is defined as the non-random occurrence of the following congenital anomalies: Vertebral, Anal, Cardiac, Tracheal-Esophageal, Renal, and Limb anomalies. As no unequivocal candidate gene has been identified yet, patients are diagnosed phenotypically. The aims of this study were to identify patients with monogenic disorders using a genetics-first approach, and to study whether variants in candidate genes are involved in the etiology of VACTERL or the individual features of VACTERL: Anorectal malformation (ARM) or esophageal atresia with or without trachea-esophageal fistula (EA/TEF). Methods:Using molecular inversion probes, a candidate gene panel of 56 genes was sequenced in three patient groups: VACTERL (n= 211), ARM (n= 204), and EA/TEF (n= 95). Loss-of-function (LoF) and additional likely pathogenic missense variants, were prioritized and validated using Sanger sequencing. Validated variants were tested for segregation and patients were clinically re-evaluated. Results:In 7 out of the 510 patients (1.4%), pathogenic or likely pathogenic variants were identified inSALL1, SALL4, andMID1, genes that are associated with Townes-Brocks, Duane-radial-ray, and Opitz-G/BBB syndrome. These syndromes always include ARM or EA/TEF, in combination with at least two other VACTERL features. We did not identify LoF variants in the remaining candidate genes. Conclusions:None of the other candidate genes were identified as novel unequivocal disease genes for VACTERL. However, a genetics-first approach allowed refinement of the clinical diagnosis in seven patients, in whom an alternative molecular-based diagnosis was found with important implications for the counseling of the families.
AB - Background:The VATER/VACTERL association (VACTERL) is defined as the non-random occurrence of the following congenital anomalies: Vertebral, Anal, Cardiac, Tracheal-Esophageal, Renal, and Limb anomalies. As no unequivocal candidate gene has been identified yet, patients are diagnosed phenotypically. The aims of this study were to identify patients with monogenic disorders using a genetics-first approach, and to study whether variants in candidate genes are involved in the etiology of VACTERL or the individual features of VACTERL: Anorectal malformation (ARM) or esophageal atresia with or without trachea-esophageal fistula (EA/TEF). Methods:Using molecular inversion probes, a candidate gene panel of 56 genes was sequenced in three patient groups: VACTERL (n= 211), ARM (n= 204), and EA/TEF (n= 95). Loss-of-function (LoF) and additional likely pathogenic missense variants, were prioritized and validated using Sanger sequencing. Validated variants were tested for segregation and patients were clinically re-evaluated. Results:In 7 out of the 510 patients (1.4%), pathogenic or likely pathogenic variants were identified inSALL1, SALL4, andMID1, genes that are associated with Townes-Brocks, Duane-radial-ray, and Opitz-G/BBB syndrome. These syndromes always include ARM or EA/TEF, in combination with at least two other VACTERL features. We did not identify LoF variants in the remaining candidate genes. Conclusions:None of the other candidate genes were identified as novel unequivocal disease genes for VACTERL. However, a genetics-first approach allowed refinement of the clinical diagnosis in seven patients, in whom an alternative molecular-based diagnosis was found with important implications for the counseling of the families.
KW - anorectal malformations
KW - duane-radial ray syndrome
KW - esophageal atresia
KW - genetics-first
KW - molecular inversion probe
KW - Opitz-G
KW - BBB syndrome
KW - townes-brocks syndrome
KW - VATER/VACTERL ASSOCIATION
KW - MOLECULAR-BASIS
KW - COPY NUMBER
KW - MALFORMATIONS
KW - MUTATION
KW - FGF8
KW - EXPRESSION
KW - NOTOCHORD
KW - SPECTRUM
KW - DEFECTS
U2 - 10.3389/fped.2020.00310
DO - 10.3389/fped.2020.00310
M3 - Article
C2 - 32656166
SN - 2296-2360
VL - 8
JO - Frontiers in pediatrics
JF - Frontiers in pediatrics
M1 - 310
ER -